Hemodynamic Effects of Bolus vs 2-h Infusion of Alteplase in Acute Massive Pulmonary Embolism
- 1 September 1994
- Vol. 106 (3) , 712-717
- https://doi.org/10.1378/chest.106.3.712
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusionThe Lancet, 1993
- Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolismThe American Journal of Cardiology, 1992
- Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trialJournal of the American College of Cardiology, 1992
- Thrombolyis for pulmonary embolismThe Lancet, 1992
- Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trialJournal of the American College of Cardiology, 1992
- Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolismEuropean Journal of Nuclear Medicine and Molecular Imaging, 1990
- RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISMThe Lancet, 1988
- ACUTE PULMONARY EMBOLISM TREATED WITH TISSUE PLASMINOGEN ACTIVATORThe Lancet, 1986
- Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial.Circulation, 1984
- Comparison of Streptokinase and Heparin in Treatment of Isolated Acute Massive Pulmonary EmbolismBMJ, 1971